Article Contents ::
Details About Generic Salt :: Vaccine Human Papilloma Virus types 6,11,16 and 18
Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
| 14D. VACCINES AND ANTI-SERA in 14. IMMUNOLOGY & ALLERGY |
| VACCINE HUMAN PAPILLOMA VIRUS TYPES 6,11,16 AND 18 |
| VACCINE, INACTIVATED (VIRAL) | QUADRIVALENT HPV VACCINE |
|
Indications & Dose: ANAL INTRAEPITHELIAL NEOPLASIA CAUSED BY HPV TYPES 6, 11, 16 AND 18 IM Adult < 26 yrs: 0.5ml followed by 0.5ml at 2 and 6 months after the initial dose Child > 9 yrs: Same as adult dose | PREVENTION OF ANAL CANCER IN MALES CAUSED BY HPV TYPES 16, AND 18 IM Adult < 26 yrs: 0.5ml followed by 0.5ml at 2 and 6 months after the initial dose Child > 9 yrs: Same as adult dose | PREVENTION OF CERVICAL, VULVAR, VAGINAL CANCER CAUSED BY HPV TYPES 6, 11, 16 AND 18 IM Adult < 26 yrs: 0.5ml followed by 0.5ml at 2 and 6 months after the initial dose Child > 9 yrs: Same as adult dose | PREVENTION OF GENITAL WARTS CAUSED BY HPV TYPES 6 AND 11 IM Adult <26 yrs: 0.5ml followed by 0.5ml at 2 and 6 months after the initial dose Child >9 yrs: Same as adult dose |
| Contra: hypersensitivity to active substances or any component of the formulation
ADR: Serious: anaphylactic/anaphylactoid reaction, bronchospasm, cellulitis, Guillian-Barre syndrome, lymphadenopathy, urticaria, transverse myelitis, motor neuron disease, syncope, acute renal failure, arthralgia, myalgia, hematoma, Others: pharyngolaryngeal pain, cough, nasal congestion, injection site joint movement impairment, headache, fever, injection site pain, swelling, erythema, dizziness, malaise, insomnia, nausea, vomiting, diarrhea, toothache, injection site pruritus, bruising DDI: Serious Immunosuppressants decreases papillomavirus vaccine effects Monitor: Syncope, fainting for 15min after administration of vaccine, gynecologic screening exam, HPV test, screening for cervical cancer |
